Artificial cells
First Claim
Patent Images
1. A composition, comprising:
- a lipid surface including at least one artificial antigen presenting cell complex, the artificial antigen presenting cell complex including at least one epitope joined to at least one MHC receptor component, and at least one cell death-initiating component.
2 Assignments
0 Petitions
Accused Products
Abstract
The present disclosure relates to various embodiments associated with artificial cells, particularly artificial antigen presenting cells, methods of making the same, methods of administering the same, computer systems relating thereto, computer-implemented methods relating thereto, and associated computer program products.
81 Citations
99 Claims
-
1. A composition, comprising:
a lipid surface including at least one artificial antigen presenting cell complex, the artificial antigen presenting cell complex including at least one epitope joined to at least one MHC receptor component, and at least one cell death-initiating component. - View Dependent Claims (2, 3, 4, 5, 6, 7, 21, 23, 24, 25, 26, 27, 28, 33, 34, 35, 37, 38, 39, 40, 41, 42, 43, 44, 45, 51, 52, 53, 54, 55, 59, 63, 64, 65, 66, 71, 72, 73, 74, 75, 76, 77, 78, 79, 81)
-
8-20. -20. (canceled)
-
22. (canceled)
-
29-32. -32. (canceled)
-
36. (canceled)
-
46-50. -50. (canceled)
-
56-58. -58. (canceled)
-
60-62. -62. (canceled)
-
67-70. -70. (canceled)
-
80. (canceled)
-
82-91. -91. (canceled)
-
92. A composition, comprising:
a modified cell including at least one artificial antigen presenting cell complex, the at least one artificial antigen presenting cell complex including at least one epitope joined to at least one MHC receptor component; and
at least one nanotube operably linked to a NKG2D receptor on the modified cell.- View Dependent Claims (93, 94, 95, 96, 97, 98, 99)
Specification